Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bayer cropscience pty ltd - dinoseb - herbicide

Australia - English - Department of Health (Therapeutic Goods Administration)

a vogel australia pty ltd - serenoa repens -

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - framycetin sulfate; gramicidin; dexamethasone - ear/eye drops, solution - 0.5 %w/v+0.005 %w/v+0.05 percent weight/volume - corticosteroids and antiinfectives in combination; dexamethasone and antiinfectives

Malta - English - Medicines Authority

lab. chimico farmaceutico a sella s.r.l via vicenza 67, schio, italy - cetylpyridinium chloride - lozenge - cetylpyridinium chloride 3 mg - throat preparations

Malta - English - Medicines Authority

sanofi malta limited - framycetin sulfate, dexamethasone, gramicidin - ear drops, solution, eye drops, solution - framycetin sulfate 0.5 percent weight/volume ; dexamethasone 0.05 percent weight/volume ; gramicidin 0.005 percent weight/volume - ophthalmological and otological preparations

Malta - English - Medicines Authority

sanofi s.r.l viale l. bodio, 37/b 20158, milan, italy - framycetin sulfate, dexamethasone, gramicidin - eye drops, solution ear drops, solution - framycetin sulfate 0.5 % (w/v) dexamethasone 0.05 % (w/v) gramicidin 0.005 % (w/v) - ophthalmological and otological preparations

United States - English - NLM (National Library of Medicine)

direct rx - cefuroxime axetil (unii: z49qdt0j8z) (cefuroxime - unii:o1r9fj93ed) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of cefuroxime axetil tablets usp and other antibacterial drugs, cefuroxime axetil tablets usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. note: cefuroxime axetil tablets usp and cefuroxime axetil for oral suspension are not bio­equivalent and are not substitutable on a milligram-per-milligram basis (see clinical pharmacology). cefuroxime axetil tablets usp: cefuroxime axetil tablets usp are indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below:   - pharyngitis/tonsillitis cause

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - cefuroxime axetil (unii: z49qdt0j8z) (cefuroxime - unii:o1r9fj93ed) - cefuroxime axetil tablets are indicated for the treatment of adult patients and pediatric patients (13 years and older) with mild-to-moderate pharyngitis/tonsillitis caused by susceptible strains of streptococcus pyogenes . limitations of use - the efficacy of cefuroxime axetil in the prevention of rheumatic fever was not established in clinical trials. - the efficacy of cefuroxime axetil in the treatment of penicillin-resistant strains of streptococcus pyogenes has not been demonstrated in clinical trials. cefuroxime axetil tablets are indicated for the treatment of pediatric patients (who can swallow tablets whole) with acute bacterial otitis media caused by susceptible strains of streptococcus pneumoniae, haemophilus influenzae (including β-lactamase–producing strains), moraxella catarrhalis (including β-lactamase–producing strains), or streptococcus pyogenes . cefuroxime axetil tablets are indicated for the treatment of adult and pediatric patients (13 years and older) with mild-to-moderate acute bac

United States - English - NLM (National Library of Medicine)

proficient rx lp - cefuroxime axetil (unii: z49qdt0j8z) (cefuroxime - unii:o1r9fj93ed) - cefuroxime axetiltablets are indicated for the treatment of adult patients and pediatric patients (13 years and older) with mild-to-moderate pharyngitis/tonsillitis caused by susceptible strains of streptococcus pyogenes . limitations of use cefuroxime axetil tablets are indicated for the treatment of pediatric patients (who can swallow tablets whole) with acute bacterial otitis media caused by susceptible strains of streptococcus pneumoniae, haemophilus influenzae (including β-lactamase–producing strains), moraxella catarrhalis (including β-lactamase–producing strains), or streptococcus pyogenes . cefuroxime axetil tablets are indicated for the treatment of adult and pediatric patients (13 years and older) with mild-to-moderate acute bacterial maxillary sinusitis caused by susceptible strains of streptococcus pneumoniae or haemophilus influenzae (non-β -lactamase–producing strains only). limitations of use the effectiveness of cefuroxime axetil for sinus infections caused by β-lactamase–producing ha

United States - English - NLM (National Library of Medicine)

direct_rx - cefuroxime axetil (unii: z49qdt0j8z) (cefuroxime - unii:o1r9fj93ed) - 1.1 pharyngitis/tonsillitis cefuroxime axetil tablets are indicated for the treatment of adult patients and pediatric patients (13 years and older) with mild-to-moderate pharyngitis/tonsillitis caused by susceptible strains of streptococcus pyogenes. limitations of use the efficacy of cefuroxime axetil in the prevention of rheumatic fever was not established in clinical trials. the efficacy of cefuroxime axetil in the treatment of penicillin-resistant strains of streptococcus pyogenes has not been demonstrated in clinical trials. 1.2 acute bacterial otitis media cefuroxime axetil tablets are indicated for the treatment of pediatric patients (who can swallow tablets whole) with acute bacterial otitis media caused by susceptible strains of streptococcus pneumoniae, haemophilus influenzae (including β-lactamase–producing strains), moraxella catarrhalis (including β-lactamase–producing strains), or streptococcus pyogenes. 1.3 acute bacterial maxillary sinusitis cefuroxime axetil tablets are indicated f